December 16, 2009
GlaxoSmithKline and NanoBio announce OTC licensing agreement for cold sore treatment
December 14, 2009
GSK publishes speaking, consulting fees paid to US healthcare professionals
December 11, 2009
GSK study showed targeted therapy combination achieved 14 month overall survival in patients with advanced breast cancer
December 11, 2009
GSK and Intercell form strategic alliance to develop and commercialise innovative needle-free patch-based vaccines
December 09, 2009
GSK initiates second pivotal Phase III trial for investigational cardiovascular medication Darapladib
December 08, 2009
Long-term Bexxar® data demonstrate overall survival
December 08, 2009
Stop-smoking gum launches new campaign showing smokers how quitting can “Suck Less”
December 01, 2009
GSK Update: GSK’s Arepanrix™ H1N1 pandemic vaccine prequalified by the World Health Organization
December 01, 2009
GSK completes extension of strategic collaboration with Aspen
November 30, 2009
GlaxoSmithKline establishes $1 million scholarship fund at The Philadelphia Foundation
November 30, 2009
GlaxoSmithKline announced as Tier 3 Sponsor as London 2012 anti-doping plans confirmed
November 30, 2009
Regulatory Update: GSK files Rotarix for prevention of rotavirus in Japan
November 24, 2009
GlaxoSmithKline and Gilead announce agreement to commercialise Viread® for chronic hepatitis B in key Asian countries
November 23, 2009
GSK Regulatory Update: Avodart
November 23, 2009
Pandemic 2009 Influenza Update: Pandemrix™ data in children and adolescents from 3 to 17 years of age
November 16, 2009
GSK and Nabi announce agreement for NicVAX®, a vaccine for nicotine addiction
November 10, 2009
Pandemic 2009 Influenza Update: US FDA approves GSK’s pandemic H1N1 vaccine
November 10, 2009
GSK signs agreement with the WHO to donate 50 million doses of pandemic H1N1 vaccine for distribution to developing countries
November 09, 2009
GlaxoSmithKline and XenoPort announce extension of GSK1838262 (XP13512) FDA review date to 9 February, 2010
November 09, 2009
Pandemic 2009 Influenza Update: Pandemrix™ data on co-administration with annual seasonal influenza vaccine (Fluarix®)
November 06, 2009
World Health Organization Grants Prequalification for Global Use to GSK’s 10-Valent Synflorix™ Vaccine
November 05, 2009
Nine area healthcare nonprofits win $40,000 each in funding from GlaxoSmithKline in partnership with the Triangle Community Foundation
November 03, 2009
World’s largest malaria vaccine trial now underway in seven African countries
November 03, 2009
ViiV Healthcare launches: A new specialist HIV company dedicated to delivering advances in HIV treatment and care
November 02, 2009
Retigabine Regulatory Update
November 02, 2009
GlaxoSmithKline and Human Genome Sciences announce positive results in second of two phase 3 trials of Benlysta in systemic lupus erythematosus
October 28, 2009
Results announcement for the third quarter 2009
October 27, 2009
Pandemic 2009 Influenza Update: Pandemrix™ data in an elderly population
October 27, 2009
GlaxoSmithKline and Theravance commence Phase III Horizon programme to develop a next-generation treatment for COPD
October 26, 2009
GSK and Genmab receive accelerated approval for Arzerra™
October 23, 2009
Pandemic (H1N1) 2009 Influenza Update: Experience of GSK’s H1N1 adjuvanted vaccine, Pandemrix™, and preliminary paediatric results
October 21, 2009
CDC Advisory Committee recommends Cervarix to prevent cervical cancer in girls and young women
October 20, 2009
GlaxoSmithKline and Human Genome Sciences announce full presentation at ACR of positive phase 3 study results for Benlysta in systemic lupus erythematosus
October 19, 2009
FDA approves GlaxoSmithKline’s Votrient™ for advanced renal cell cancer
October 16, 2009
FDA approves Cervarix, GlaxoSmithKline’s cervical cancer vaccine
October 16, 2009
Pandemic (H1N1) 2009 Influenza Update: Results from second clinical trial of GSK’s H1N1 adjuvanted vaccine confirm immune response and tolerability
October 16, 2009
GSK’s Cervarix® becomes the first cervical cancer vaccine to gain approval in Japan
October 13, 2009
GSK Statement on Jury Verdict in Paxil Product Liability Trial in Philadelphia Court of Common Pleas
October 13, 2009
GlaxoSmithKline and Prosensa form alliance to fight Duchenne Muscular Dystrophy
October 13, 2009
GSK partners with UK Government and Wellcome Trust to stimulate innovation through the creation of a world-class science park
October 12, 2009
GSK’s Avodart® / tamsulosin combination showed benefits for men with prostate enlargement
October 08, 2009
GlaxoSmithKline and U.S. Patent and Trademark Office file a motion to dismiss litigation over Final Regulations
October 06, 2009
GSK expands presence in China through strategic cooperation to form a joint venture on paediatric vaccines
October 06, 2009
GlaxoSmithKline update: Government orders for pandemic (H1N1) 2009 vaccine
October 05, 2009
Positive phase II results for GSK1838262 (XP13512) reported for subjects with post-herpetic neuralgia and a history of inadequate response to gabapentin
October 01, 2009
GlaxoSmithKline applauds compassion, competence, passion and perseverance in North Carolina’s child advocates
October 01, 2009
Avodart (dutasteride) Regulatory Update
September 30, 2009
Pandemic (H1N1) 2009 Influenza Update: GSK’s H1N1 ‘Pandemrix’ vaccine receives European Commission Approval
September 29, 2009
GlaxoSmithKline Update on FDA Review of Cervarix
September 28, 2009
GSK provides update on regulatory filings for Zunrisa/Rezonic
September 25, 2009
Pandemic (H1N1) 2009 Influenza Update: GSK’s H1N1 ‘Pandemrix’ vaccine receives positive opinion from European Regulators
September 22, 2009
GlaxoSmithKline named a 2009 100 Best Company By Working Mother Magazine
September 22, 2009
GlaxoSmithKline Receives Perfect Score on Corporate Equality Index
September 21, 2009
GSK limits medical education funding to independent programs with highest impact on patient care
September 17, 2009
Positive phase IIb results for GSK1838262 (XP13512) reported for neuropathic pain associated with post-herpetic neuralgia
September 16, 2009
GSK makes it easier for unemployed, uninsured to get free medicines
September 14, 2009
Pandemic (H1N1) 2009 Influenza Update: Initial results from first clinical trial of GSK’s H1N1 adjuvanted vaccine
September 10, 2009
GSK named to AARP list of 2009 Best Employers for Workers Over 50
September 09, 2009
FDA Advisory Committee makes favorable recommendation for Cervarix, GlaxoSmithKline’s candidate cervical cancer vaccine
September 08, 2009
New gel technology reaches hidden areas of the mouth
September 02, 2009
FDA states consumers should continue to use alli
August 25, 2009
GSK advisory: Warehouse theft
August 19, 2009
FDA approves GSK's HIB vaccine, Hiberix®
August 17, 2009
GlaxoSmithKline and Genmab announce results from a study of Arzerra in rituximab refractory follicular NHL
August 17, 2009
GSK and Brazil’s Fiocruz form partnership for new R&D effort and increased vaccine access
August 14, 2009
Pandemic (H1N1) 2009 influenza update
August 13, 2009
Shionogi-GlaxoSmithKline Pharmaceuticals acknowledges position of the European AIDS Treatment Group and the AIDS Treatment Activists Coalition to revise protocol for ING112276, a clinical study for S/GSK1349572
August 04, 2009
GlaxoSmithKline update: Government orders for pandemic (H1N1) 2009 vaccine
July 29, 2009
GlaxoSmithKline and Genmab announce top-line results for ofatumumab in rheumatoid arthritis
July 29, 2009
Regulatory update: mepolizumab for the treatment of hypereosinophilic syndrome (HES)
July 27, 2009
Amgen to collaborate with GSK to commercialize denosumab in Europe for postmenopausal osteoporosis (PMO)
July 22, 2009
GlaxoSmithKline completes acquisition of Stiefel
July 22, 2009
Results announcement for the second quarter 2009
July 22, 2009
Pandemic (H1N1) 2009 Influenza Update
July 21, 2009
GSK and Enigma Diagnostics announce commercial partnership to develop point-of-care influenza diagnostics
July 21, 2009
Antiviral activity of S/GSK1349572, the only once-daily, unboosted integrase inhibitor in clinical development, evaluated in phase 2 study
July 20, 2009
GlaxoSmithKline, Morehead offer "Science in the Summer"
July 20, 2009
Human Genome Sciences and GlaxoSmithKline announce positive Phase 3 study results for Benlysta™ in systemic lupus erythematosus
July 14, 2009
GSK announces new commitments to fight HIV/AIDS in Sub-Saharan Africa - special focus on care and treatment of children
July 08, 2009
Alnylam joins GSK in donating intellectual property to patent pool for neglected tropical diseases
July 07, 2009
Landmark study for GSK’s cervical cancer vaccine published in The Lancet
July 02, 2009
GSK further extends its product portfolio in the Middle East and North Africa
June 23, 2009
Regulatory update for REZONIC™ (casopitant mesylate)
June 16, 2009
FDA extends review of Arzerra™ (ofatumumab)
June 15, 2009
GSK announces a strategic alliance with Dr. Reddy’s to further accelerate sales growth in emerging markets
June 12, 2009
GlaxoSmithKline update: A (H1N1) influenza
June 10, 2009
Summer Hints For Those with Type 2 Diabetes and Very High Triglycerides: Getting Fit Could Mean Getting More Fat –The Good Kind
June 09, 2009
GSK and Shenzhen Neptunus create new alliance to develop and manufacture influenza vaccines in China
June 05, 2009
Large, long-term study shows Avandia has no increased overall cardiovascular risk compared to other commonly used diabetes medicines
June 03, 2009
GSK donates $100,000 to support breast health outreach
June 02, 2009
GSK and Concert Pharmaceuticals form alliance to develop novel deuterium-modified drugs
June 01, 2009
GSK’s Pazopanib significantly delayed tumor progression in patients with advanced kidney cancer
June 01, 2009
FDA approves Lamictal®XR™; an extended-release once-daily, new generation treatment for epilepsy
May 29, 2009
FDA advisory panel makes favorable recommendation for ARZERRA (ofatumumab)
May 22, 2009
US Department of Health and Human Services (HHS) purchases GSK’s A (H1N1) influenza antigen and proprietary adjuvant system
May 15, 2009
GlaxoSmithKline update: A (H1N1) influenza vaccine development
May 13, 2009
FDA Advisory Committee Meeting for GSK’s Rezonic® Cancelled
May 13, 2009
Research findings on nine GlaxoSmithKline cancer compounds to be presented at ASCO 2009
May 12, 2009
GSK extends strategic collaboration with Aspen
May 11, 2009
FDA approves Lamictal® ODT™ Orally Disintegrating Tablets
May 08, 2009
New data for GlaxoSmithKline’s vaccine, Cervarix®, presented at IPV Conference
May 06, 2009
GlaxoSmithKline to divest US rights for Wellbutrin XL® to Biovail for $510 million
May 01, 2009
GlaxoSmithKline update: influenza A (H1N1)
April 27, 2009
Large, long-term study shows dutasteride reduced prostate cancer risk in men at increased risk of the disease
April 27, 2009
Emergence of a new H1N1 influenza A strain (swine influenza)
April 27, 2009
Phase II results for GSK1838262 (XP13512) reported for neuropathic pain associated with diabetic peripheral neuropathy
April 20, 2009
GlaxoSmithKline and Stiefel to create new world-leading specialist dermatology business
April 16, 2009
GlaxoSmithKline and Pfizer announce innovative agreement to create a new world-leading, specialist HIV company
April 09, 2009
Diabetes Ten City Challenge reduces health care costs and improves patient health
April 08, 2009
Heartburn sufferers find lasting relief with TUMS® dual action
April 01, 2009
GSK submits Tyverb®/Tykerb® (lapatinib) for first-line treatment of metastatic breast cancer in Europe, US
March 31, 2009
Federal cigarette tax increase and current economy will change smoker’s habits
March 31, 2009
GlaxoSmithKline and Shire Enter Agreement to Co-Promote Vyvanse® (lisdexamfetamine dimesylate) CII for Adult Attention Deficit Hyperactivity Disorder
March 30, 2009
Cervarix® U.S. regulatory update
March 25, 2009
GlaxoSmithKline global collaboration identifies two new genes for COPD
March 19, 2009
GlaxoSmithKline announces sale of shares in Quest Diagnostics Inc.
March 19, 2009
GSK sponsored prescription savings program, Together Rx Access, expands eligibility criteria
March 17, 2009
GlaxoSmithKline awards ten healthcare nonprofits with $40,000 each in funding
March 12, 2009
Wynonna Judd and alli to host private concert
March 11, 2009
Prasco selected as GSK’s generics marketing and distribution agent
March 10, 2009
GSK Consumer Healthcare helps to bridge oral care gap in Appalachia
March 04, 2009
GlaxoSmithKline submits European marketing authorisation application for Pazopanib in advanced kidney cancer
March 02, 2009
Ample supplies of Relenza available as flu season peaks
February 25, 2009
Wynonna Judd and alli hit the road for a healthier America
February 17, 2009
GSK initiates phase III programme for novel type 2 diabetes medication, Syncria® (albiglutide)
February 06, 2009
GlaxoSmithKline and Idenix Pharmaceuticals sign worldwide license agreement for IDX899, a novel NNRTI for the treatment of HIV
February 05, 2009
GlaxoSmithKline and Genmab seek European marketing authorisation of Arzerra™ (ofatumumab) in advanced stage blood cancer
February 05, 2009
Results announcement for the fourth quarter 2008
February 04, 2009
GSK and Theravance announce positive phase 2b results for once-daily fluticasone furoate in the treatment of asthma
February 02, 2009
GlaxoSmithKline plc, announces board changes
January 30, 2009
GlaxoSmithKline and Genmab submit Arzerra (Ofatumumab) application to FDA for the treatment of advanced stage blood cancer
January 30, 2009
Deirdre Connelly to join GSK as President, North American Pharmaceuticals
January 29, 2009
GSK announces charges for legal matters
January 29, 2009
The UK Government signs influenza pandemic contract with GlaxoSmithKline for Relenza®
January 19, 2009
GlaxoSmithKline awards ten area healthcare nonprofits with $40,000 each in funding
January 09, 2009
GSK and Xenoport resubmit new drug application for Solzira™ in restless legs syndrome
January 07, 2009
Wynonna Judd reveals her alli®, her story for finding a healthier lifestyle